Description: Samyang Holdings Corporation, together its subsidiaries, engages in chemical, food, packaging, pharmaceutical, and other businesses in South Korea. It produces and sells value-added materials, terephthalic acid, polycarbonate (PC) resins, bisphenol-A, engineering plastics, PC and polybutylene terephtalate compounds, PET bottles, and long fiber reinforced thermoplastics. It offers health and wellness products, and starch sugar; and operates a salad & brunch concept restaurant under the Seven Springs name, as well as a bakery under the Café Seven Springs name. In addition, the company develops and sells anti-cancer drugs, such as Genexol and Nanoxel PM; NicoStop, a smoking cessation patch; and biodegradable sutures, including Trisorb and Monosorb, as well as exports its products to 80 countries. Further, it provides IT services comprising IT consulting on system management and integration, and e-business services, as well as solutions in ERP, e-HR, MES, and mobile services to the public, finance, and manufacturing sectors. Samyang Holdings Corporation was founded in 1924 and is based in Seoul, South Korea.
Home Page: www.samyang.com
31 Jongno 33-gil
Seoul,
South Korea
Phone:
82 2 740 7111
Officers
| Name | Title |
|---|---|
| Mr. Jeong Kim | Pres |
| Mr. Ji-Seop Kim | MD & Chief of Fin. Office |
| Mr. Jae-Yeob Yun | VP & Head of MSC |
| Mr. Kwang-Yeol Kim | MD & Chief of Management Support Office |
| Mr. Kyu-Hoon Song | MD & Chief of SCM Office |
| Mr. Young-Joo Choi | MD & Mang. of Management Diagnosis Team, CPC |
| Mr. Tak-Heon Lee | MD & Mang. of Legal Support Team - Management Support Office |
| Mr. Jae-Hong Kim | MD & Head of CPC |
| Mr. Sang-Hun Lee | MD & Head of IC |
Exchange: KO
Country: KR
Currency: Korean Won (₩)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.2502 |
| Price-to-Sales TTM: | 0.1687 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |